Delcath Systems Inc (DCTH)

[SAMNOTSAMUEL]

Every way possible, not very encouraging methodology. Stop to consider that not all locations may have worked out, also consider the transition to a wider criteria of patients allowed is not possibly a seamless transition.

Last but not least, I would have to have looked over your shoulder apparently. Simpson imo knows what she is doing.

So to me the real issue is whether phase 3 is likely to be complete by end of 2019. Then allow 12 months for submission and fda approval. This company has lots of dilution ahead before phase 3 valuation turns really red hot